Dystonia is an abnormal involuntary movement or posture owing to sustained or intermittent muscle contraction. Standard treatment for dystonia includes medications, such as levodopa, anticholinergic and antiepileptic drugs, botulinum toxin, and baclofen pump, and surgeries, such as lesioning surgery and deep-brain stimulation. New treatment modalities aimed toward improving dystonia care in the future are under investigation. There are two main axes to improve dystonia care; one is non-invasive neuromodulation, such as transcranial magnetic stimulation, transcranial electrical stimulation, and transcutaneous electrical nerve stimulation. The other is a quantitative evaluation of dystonia using a wearable device and motion-capturing system, which can be empowered by artificial intelligence. In this article, the current status of these axes will be reviewed.

肌张力障碍是由于持续或间歇性肌肉收缩引起的异常不自主运动或姿势。肌张力障碍的标准治疗包括药物治疗，如左旋多巴、抗胆碱能药和抗癫痫药、肉毒杆菌毒素和巴氯芬泵，以及手术，如损伤手术和深部脑刺激。旨在改善未来肌张力障碍护理的新治疗方式正在研究中。改善肌张力障碍护理有两个主轴；一种是非侵入性神经调节，如经颅磁刺激、经颅电刺激、经皮神经电刺激等。另一种是使用可穿戴设备和动作捕捉系统对肌张力障碍进行定量评估，可以通过人工智能进行赋能。在本文中，